A detailed history of Bank Of Jackson Hole Trust transactions in Gilead Sciences, Inc. stock. As of the latest transaction made, Bank Of Jackson Hole Trust holds 15 shares of GILD stock, worth $1,458. This represents 0.0% of its overall portfolio holdings.

Number of Shares
15
Holding current value
$1,458
% of portfolio
0.0%

Shares

1 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2024

Jan 31, 2025

BUY
$83.95 - $97.9 $1,259 - $1,468
15 New
15 $1.39 Million

Others Institutions Holding GILD

About GILEAD SCIENCES, INC.


  • Ticker GILD
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 1,253,369,984
  • Market Cap $122B
  • Description
  • Gilead Sciences, Inc., a biopharmaceutical company, discovers, develops, and commercializes medicines in the areas of unmet medical need in the United States, Europe, and internationally. The company provides Biktarvy, Genvoya, Descovy, Odefsey, Truvada, Complera/ Eviplera, Stribild, and Atripla products for the treatment of HIV/AIDS; Veklury, a...
More about GILD
Track This Portfolio

Track Bank Of Jackson Hole Trust Portfolio

Follow Bank Of Jackson Hole Trust and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Bank Of Jackson Hole Trust, based on Form 13F filings with the SEC.

News

Stay updated on Bank Of Jackson Hole Trust with notifications on news.